Although lentiviral vector production techniques have matured in recent years with companies such as OriGene Technologies now offering an array of lentiviral vectors and particles to address ...

October 1, 2015 (Vol. 35, No. 17) Evolving from a Gene-Based Tool Provider to a Premier Antibody Supplier, for Both Research and Diagnostic Fields OriGene Technologies was founded in 1996 as a […] ...

SAN DIEGO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today ...

ROCKVILLE, Md., Feb. 11 /PRNewswire/ -- OriGene Technologies, Inc. ("OriGene") today announced it has raised an additional $6.5 million in a private equity financing. With this financing, OriGene ...

In addition, the characterization of this ancient lentivirus in lemurs raises the possibility that HIV-like retroviruses are still circulating today in the mammalian fauna of Madagascar.

OriGene Technologies was founded in 1996 as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector.